Advertisement

Topics

Companies Related to "Could SWITCHing Insulin Degludec Thwart Hypoglycemia" [Most Relevant Company Matches] RSS

03:08 EDT 20th June 2018 | BioPortfolio

Here are the most relevant search results for "Could SWITCHing Insulin Degludec Thwart Hypoglycemia" found in our extensive corporate database of over 50,000 company records.

Showing "Could SWITCHing Insulin Degludec Thwart Hypoglycemia" Companies 1–25 of 114

Extremely Relevant

DiObex, Inc.

DiObex is a biotechnology company engaged in the development of novel products for metabolic disease. DIO-901 (very low dose glucagon) is in development in two convenient delivery forms for the prevention of nocturnal hypoglycemia induced by insulin intensification. Insulin-induced hypoglycemia, which occurs most frequently at night, is a major limitation in the aggressive management of hype...


Relevant

NiliMEDIX

NiliMEDIX develops innovative durable (to be used for several years) and disposable (replaced every 2-3 days) insulin pumps for helping diabetics manage their diabetes.Insulin pumps deliver insulin the way a healthy pancreas does allowing freedom in daily activities and improving the quality of life of their users.Moreover, the pumps usually decrease the needed daily amount of insulin by reducing ...

Tandem Diabetes Care®, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump current...


Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump current...

Medtronic Diabetes

At Medtronic Diabetes, our 20 plus year history vividly reflects our dedication and ongoing vision to develop an "artificial pancreas". In 1983, we pioneered the idea of continuous insulin delivery, introducing our first insulin pump in an effort to find a "better way" to deliver insulin for people with diabetes. Since that time, Medtronic Diabetes has remained the market leader, earning a reputat...

Glytec

Founded in 2006, Glytec is a rapidly growing clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control. The eGlycemic Management System™ (eGMS™) enables hospitals and healthcare systems to significantly reduce the frequency, risks and costs of hyperglycemia and hypoglycemia and of...

Zucara Therapeutics

Zucara Therapeutics, a spin-off company by The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI), is developing the first drug therapy to prevent hypoglycemia in people with diabetes. The Company’s first-in-class therapeutic is aimed at inhibiting a hormone in the pancreas called somatostatin, which does not function properly in ...

Glytec, LLC

Founded in 2006, Glytec is a rapidly growing clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control. The eGlycemic Management System™ (eGMS™) enables hospitals and healthcare systems to significantly reduce the frequency, risks and costs of hyperglycemia and hypoglycemia and of...

Waratah Pharmaceuticals

Waratah is a dynamic young biopharmaceutical company founded in April 2000 as a spin-off of RTP Pharma Inc. to develop and commercialize products for its novel, patented therapy – Islet Neogenesis Therapy (I.N.T.™) for the treatment of insulin-dependent diabetes. Diabetes is a disease in which the body does not produce or properly use insulin because of damaged or destroyed insulin producing i...

MannKind

MannKind is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Our lead investigational product candidate, Technosphere® Insulin System, is currently in phase 3 clinical trials in the U.S. and Europe to study its safety and efficacy in the treatment of diabetes. This therapy consists of a propri...

Mellitus Health

Founded in 2014 as Insulin Algorithms by Mayer Davidson, MD, Josh Davidson and Michael Margolese, the Los Angeles firm rebranded in 2018 as Mellitus Health, Inc. Its cloud-based insulin titration software works with all insulins and combinations and all 125 dosing regimens, providing precision insulin dosing recommendations to clinicians in just seconds. T...

Insulet Corporation

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its Omnipod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The Omnipod is a revolutionary and easy-to-use tubeless insulin pump tha...

Hygieia, Inc.

Hygieia, Inc. is an emerging diabetes health care company developing new ways to improve the effectiveness of therapy while reducing the cost of diabetes care. Hygieia’s first product is a handheld Diabetes Insulin Guidance System (DIGS™) designed to improve insulin therapy effectiveness for patients. DIGS works in a way that makes it a feasible ...

Dance Pharma

Dance is a San Francisco based, global company focused exclusively on creating a line of small, patient friendly, pain-less, low cost insulin inhalers for the world diabetes market. In addition to providing inhaled insulin to those who have become insulin dependent, the company also intends to enable introduction of insulin much earlier in the disease proc...

Rheodyne LLC

Since Rheodyne's founding in 1976, our development laboratories have consistently produced innovative fluid switching designs. Early attention focused on HPLC, which was then experiencing explosive growth in its infancy. Sample InjectorsRheodyne's first manual sample injector (1976) was the pioneering Model 7105. This injector has evolved through four generations to the current Model 7725, which i...

Mellitus Health, Inc.

Mellitus Health automates algorithmic dosing of insulin, offering clinicians precision recommendations in seconds. Founded in 2014 as Insulin Algorithms by Mayer B. Davidson, MD, Josh Davidson and Michael Margolese, the Los Angeles firm rebranded in 2018 as Mellitus Health, Inc.

Calibra Medical Inc.

Calibra Medical Inc. is a medical device company developing small, simple, cost-effective drug delivery systems. The company’s first product, Finesse, is designed to improve mealtime insulin therapy delivery. Calibra is seeking to improve care for people with diabetes by simplifying insulin delivery, thereby improving patient adherence to their physic...

Bigfoot Biomedical, Inc.

Bigfoot Biomedical was founded by a team of people with a personal connection to type 1 diabetes and, with its Loop and Inject services, seeks to change the paradigm of care for insulin-requiring diabetes by leveraging data, connectivity, automation, and machine learning to reduce the burden on people with insulin-requiring diabetes and maximize the levera...

DreaMed Diabetes

DreaMed Diabetes was established in 2014 to develop and commercialize diabetes treatment and management solutions. Its flagship product, GlucoSitter™, is a closed-loop insulin delivery system for patients with type 1 and type 2 diabetes. Additional development programs include insulin-treatment-profiling systems for diabetic clinics, patient decision-...

Islet Sciences, Inc.

Islet Sciences is a development-stage biotechnology company with patented technologies focused on infusion therapy for people with insulin-dependent diabetes. The Company's infusion technology includes methods for the culturing, isolation, maturation, and immunoprotection (microencapsulation) of islet cells. The Company's mission includes the introduction ...

Novocell, Inc.

Novocell is a preclinical therapeutic company focused on diabetes. Our therapy is based on the encapsulation and implantation of pancreatic beta cell progenitors (Pro-Islet-1) derived from human stem cells which secrete insulin in patients. Our goal is that Pro-Islet-1 can free both Type 1 and Type 2 diabetic patients from insulin dependence on a long term basis, while reducing or eliminating hy...

Valeritas LLC

Valeritas is a medical technology company committed to the development and commercialization of innovative drug delivery solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of diabetes. The Valeritas medical technologies portfolio is headlined by the h-Patch(TM) technology. The V-Go Disposable Insulin Delivery Device, designed for the...

MicroIslet

MicroIslet Inc. is a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes. MicroIslet has licensed several technologies from Duke University Medical Center that were developed over the last decade for the isolation, culture, storage and encapsulation of insulin-producing porcine ...

Insulin Angel

IBT

ibt develops, manufactures and distributes reagents (monoclonal and polyclonal antibodies, proteins, peptides, antigens) for infectious disease research, transcription, growth factor and cytokine research and assay kits for the detection of growth factors, e.g. insulin-like growth factors (IGF´s) and insulin-like growth factor binding proteins (IGFBP´s).


More From BioPortfolio on "Could SWITCHing Insulin Degludec Thwart Hypoglycemia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks